Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

SWITZERLAND: VIFOR TO EXTEND SITE IN ST. GALLEN

Article Abstract:

Swiss producer of pharmaceutical iron preparations Vifor International AG will invest SFr 30mn in extending its site in St. Gallen. The subsidiary of Galenica AG targets to carry out the extension in steps until 2005. Vifor plans to add ten staff to its present 110 workforce by the end of 2001. Vifor had acquired the site in St. Gallen from B. Braun Medical in 1999.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
Capital expenditures, Drugs, Blood Disease Preps, Hematinic Preparations, Hematologic agents, Hematinics, Vifor International AG

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

SWITZERLAND: NEW BIOMATERIAL FOR MEDICINE

Article Abstract:

A new biomaterial developed at the Zurich Polytechnic, ETH Zurich, in Switzerland is to be tested in pre-clinical studies. The material based on fibrin was successfully used to repair injuries to nerves. It is said that treatment by electrostatic binding of substances to proteins might be an option also in the regeneration of bone and skin tissue.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
Surgical Appliance and Supplies Manufacturing, Surgical appliances and supplies, Surgical Dressings & Sutures

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

GERMANY: NEW BETA-INTERFERON DEVELOPED

Article Abstract:

A beta-interferon of the second generation has been developed at the Fraunhofer Institute IGB in Stuttgart, Germany. A patent application has been filed for the technology with improved solubility, which is based on hydrophobic engineering. Beside the treatment of multiple sclerosis, it could be used in other indications as well.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
Ethical Preparations, Drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Switzerland, Central nervous system agents
Similar abstracts:
  • Abstracts: SWITZERLAND: CIBA INVESTING IN HALS. GERMANY: JOINT VENTURE FOR CONSTAB, RESINEX
  • Abstracts: GERMANY: SCHERING IN CONTRAST AGENT DEAL. GERMANY: NEW TEST FOR THROMBOSIS THERAPY MONITORING
  • Abstracts: GERMANY: GROWTH FOR PLASTICS INDUSTRY IN 2000. Germany: Plastic industry revises forecast downwards. GERMANY: ALPHACAN OMNIPLAST TO CLOSE PLANT
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.